Researchers
Miljković, Đorđe
Results 21-40 of 213
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity![]() | Lazarević, Milica | Article | 21a+M21a+ |
| 2024 | Anti-Neuroinflammatory Effects of a Novel Bile Acid Derivative | Bjedov, Srđan | Article | 21M21 |
| 2024 | Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate | Stegnjaić, Goran | Article | 22M22 |
| 2024 | Investigation of brain inflammation in complete Freund’s’ adjuvant-free experimental autoimmune encephalomyelitis![]() | Stanisavljević, Suzana | Conference Paper | Mp. category will be shown later |
| 2023 | Molecular biomarkers as a prognostic tool for clinical courses of experimental autoimmune encephalomyelitis in rats immunized with spinal cord homogenate | Stegnjaić, Goran | Conference Paper | Mp. category will be shown later |
| 2023 | Immunomodulatory properties of HYCOs, NRF2 activators that simultaneously release carbon monoxide (CO) to cells and tissues | Stegnjaić, Goran | Conference Paper | Mp. category will be shown later |
| 2023 | ILC3: a case of conflicted identity | Koprivica, Ivan | Article | 21M21 |
| 2023 | Distinct clinical outcomes of Complete Freund’s adjuvant-free experimental autoimmune encephalomyelitis induced in DA rats | Lazarević, Milica | Conference Paper | Mp. category will be shown later |
| 2023 | HYCO-3, an Nrf2 activator that simultaneously releases carbon monoxide (CO), ameliorates type 1 diabetes in a mouse model | Mićanović, Dragica | Conference Paper | Mp. category will be shown later |
| 2022 | Etil-piruvat i autoimunske bolesti![]() | Gajić, Dragica | Conference Paper | Mp. category will be shown later |
| 2022 | Ethyl pyruvate, a versatile protector in inflammation and autoimmunity.![]() | Koprivica, Ivan | Article | 21M21 |
| 2022 | Phenethyl ester of rosmarinic acid ameliorates experimental autoimmune encephalomyelitis | Stegnjaić, Goran | Article | 22M22 |
| 2022 | The effect of a gallic acid derivative on encephalitogenic cells | Stegnjaić, Goran | Conference Paper | Mp. category will be shown later |
| 2022 | Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis![]() | Stegnjaić, Goran | Article | 21M21 |
| 2021 | Redox Regulation of Tolerogenic Dendritic Cells and Regulatory T Cells in the Pathogenesis and Therapy of Autoimmunity | Saksida, Tamara | Article | 21aM21a |
| 2021 | Ethyl Pyruvate Ameliorates Experimental Autoimmune Myocarditis![]() | Gajić, Dragica | Article | 21M21 |
| 2021 | Ethyl pyruvate ameliorates experimental autoimmune myocarditis![]() | Gajić, Dragica | Conference Paper | Mp. category will be shown later |
| 2021 | Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy![]() | Mansilla, M. J.; Presas-Rodríguez, S.; Teniente-Serra, A.; González-Larreategui, I.; Quirant-Sánchez, B.; Fondelli, F.; Đedović, Neda
Trzonkowski, P.; Ramo-Tello, C.; Martínez-Cáceres, E. M.;
| Reviews | 21a+M21a+ |
| 2021 | Benfotiamine Reduces Dendritic Cell Inflammatory Potency. | Đedović, Neda | Article | 22M22 |
| 2021 | Sepsis and multiple sclerosis: Causative links and outcomes | Miljković, Đorđe | Article | 22M22 |
